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Aim. To evaluate the anatomical success and complication rate of Surgisis in the repair of anterior and posterior vaginal wall
prolapse. Methods. A retrospective review of 65 consecutive Surgisis prolapse repairs, involving the anterior and/or posterior
compartment, performed between 2003 and 2009, including their objective and subjective success rates using the pelvic organ
prolapse quantiﬁcation (POPQ) system. Results. The subjective success rate (no symptoms and no bulge beyond the hymen)
was 92%, and the overall objective success rate (no subsequent prolapse in any compartment) was 66% (43 of 65). The overall
reoperation rate for de novo and recurrent prolapse was 7.7% with 3 women undergoing repeat surgery at the same site (anterior
compartment).Nolong-termcomplicationsoccurred.Conclusions.Surgisishasadeﬁniteroleinthesurgicaltreatmentofprolapse.
It may decrease recurrences seen with native tissue repair and long-term complications of synthetic mesh. Its use in posterior
compartment repair in particular is promising.
1.Introduction
The satisfactory surgical treatment of vaginal prolapse
continues to elude gynaecologists, as evidenced by reports
of failure rates ranging from 30% to 70% and a reoperation
rate of 30% [1–3]. Permanent prostheses and mesh kits have
been introduced in an attempt to improve these ﬁgures, but
their use has been tempered by complications and long-term
sequelae related to the techniques and materials used [4, 5].
Jia et al. [5] reviewed rates of objective failure and
reoperation for failures and mesh excision of absorbable,
biological, and nonabsorbable mesh in 3,000 women. For
the anterior compartment, the objective failure rates for no
mesh, absorbable mesh, biological grafts, and permanent
mesh were, respectively, 29%, 23%, 18%, and 9%. However,
synthetic mesh was associated with a reoperation rate of
6.6%. Biological grafts had a reoperation rate of 3%, and
surgery for mesh excision occurred in another 2.6%. For
the posterior compartment, there were insuﬃcient data
to determine success rates. In comparison to native tissue
repair, there was a trend toward lower failure rates with
absorbable and nonabsorbable synthetic meshes but higher
failure rates with biological grafts. However, there is much
heterogeneity in biological grafts, and most studies evaluated
by Jia et al. [5] used a porcine dermal graft.
Surgisis (Cook Surgical, Bloomington, IN) is a biological
graft extracted from porcine small intestinal submucosa.
In comparison to porcine dermal grafts, Surgisis has a
higher collagen content, is acellular, and not cross-linked.
In vivo, these characteristics result in graft resorption and
replacementbyhostconnectivetissue.Thismayreducelong-
term complications, but concerns have been raised about
the durability of the resultant repair [6]. To date, very
few studies have been published on the use of Surgisis for
vaginal prolapse repair [7–10]. The aim of this study was to
determine the success and complication rates of Surgisis in
the treatment of anterior and posterior vaginal prolapse over
a six-year period.
2.SurgicalProceduresandMethods
From 2003 to 2009, 65 women with pelvic organ prolapse
have been treated with Surgisis xenograft by four surgeons2 Obstetrics and Gynecology International
at the Flinders Urogynaecology Unit. Women treated with
Surgisiswerethoseconsideredathighriskofrecurrencefrom
traditionalcolporrhaphyorwhohadarecurrenceafterprevi-
ous surgery. The treatments involved the anterior, apical, or
posterior compartment, singularly or in combination, with
the surgical technique adapted accordingly. Concomitant
procedures, such as hysterectomy and urethral sling, were
performed as clinically indicated.
For anterior repair, a midline vaginal incision is made
from the bladder neck to the anterior fornix, followed by
dissection from the pubocervical fascia at the bladder neck
to the white line laterally and ischial spines superiorly.
A protruding bulge, if present, is reduced with a purse
string suture or midline plication. Next, a patient-tailored
trapezoid-shaped graft is cut from a 10 × 7cm sheet of
four-layer Surgisis, partially rehydrated, and sutured to the
boundaries of the anterior compartment to achieve a snug
ﬁt. The graft is ﬁrst attached at the apex. With intact
apical support, the graft is attached to the cervix or the
vault scar. When apical support is deﬁcient, it is sutured to
the sacrospinous ligaments vaginally or to the uterosacral
ligaments laparoscopically. The distal part of the graft is
laterally attached to the white line at the level of the bladder
neck and then transversally sutured to the bladder neck.
For the posterior compartment, repair starts with an
inverted T incision beginning at the hymen and ending
below the posterior fornix. The dissection is carried apically
to the ischial spines, laterally to the pelvic side wall, and
distally to the perineal body fascia. The apical arms of the
graft are attached ﬁrst. Then, the distal portion is trimmed
and attached snugly to the perineal body fascia. Tacking
sutures are placed to close the gap between the pelvic side
wall and the lower half of the graft.
With combined anterior and posterior prolapse, a 20 ×
7cmfour-layerSurgisisgraftiscutandfoldedtocreateapical
arms with anterior and posterior trapezoid extensions. The
graft is attached superiorly with a nonabsorbable suture;
elsewhere, a delayed absorbable suture is used. Redundant
vaginal skin is trimmed and the wound closed with locking
absorbable suture.
Cystoscopy is performed after anterior repair and a
suprapubic catheter inserted under vision. Rectal examina-
tion is conducted after posterior repair to ensure absence of
suturematerialintherectumandexcludecompressionofthe
rectum.
Postoperatively, women are reviewed at six weeks, six
months, annually up to three years, and then biannually. At
each review, they are questioned about prolapse symptoms
and bowel, bladder, and sexual function. POPQ assessments
[11] are made at each visit. Objective success is deﬁned as
POPQ Stage 0 or 1 in all compartments and objective failure
as Stage 2 or more in any compartment. Subjective success
is deﬁned as having no more than an asymptomatic bulge
not protruding beyond the hymen and subjective failure
as a recurrence of symptoms with no objective prolapse.
Complications were classiﬁed and coded according to the
International Urogynecological Association (IUGA) and
International Continence Society (ICS) joint terminology
and classiﬁcation of the complications related to the use of
prostheses and grafts [12].
The study was approved by the Flinders Ethical Commit-
tee as an audit activity.
3. Results
Table 1 summarizes the preoperative characteristics of our
cohort. Of 65 women treated with Surgisis, 39 (60%) under-
went an anterior and posterior repair. Sixteen (25%) had a
posterior repair only and 10 (15%) an anterior repair only.
Forty-fourprocedures(68%)involvedattachmentofSurgisis
to either the sacrospinous or uterosacral ligaments. Other
concomitant procedures included hysterectomy (37%), con-
tinence surgery (15%), hysteropexy (10%), and native tissue
repair of another compartment (7.7%). Twenty-three of the
total of 103 concomitant procedures were laparoscopically
assisted, and none involved open abdominal surgery.
The average duration of the combined procedures was
102 minutes with a median of 150 minutes (range: 50–
240). Median estimated blood loss was 300mL (range: 20–
1.550mL). Median duration of hospitalisation was 4 days
(range: 2–43), and mean followup was 75 weeks.
Major surgical complications occurred in 4 women
(6.2%). Three had an estimated blood loss >1.000mL or
required transfusion (IUGA/ICS classiﬁcation [12]: 7A.T1).
One woman suﬀered a small bowel injury not recognised
at the time of laparoscopy (5C.T1.S5). Other complica-
tions included 13 (20.0%) vaginal/pelvic infections treated
with oral antibiotics (1C.T2.S1/S2), 11 (16.9%) urinary
tract infections, 12 women (18.5%) required a suprapubic
catheter for more than 7 days (4B.T2), and 7 (10.8%)
reportedeitherpersistentordenovodyspareunia(1B.T4.S2).
There were no cases of graft exposure, erosion, rejection, or
seroma formation.
The objective success rate (POPQ Stage 0 or 1 in all
compartments) was 66% (43 of 65). Of 22 objective failures,
16 had an asymptomatic bulge above the hymen giving
a subjective success rate of 92%. Three women (4.6%)
had repeat surgery; two are planning further surgery; one
remained symptomatic but declined further surgery.
Table 2 showsthesuccessratepercompartmentrepaired,
and Table 3 shows the sites aﬀected by recurrence or subse-
quentprolapse.Of10womenintheanterioronlygroup,four
developed further prolapse: one recurrence of cystocoele and
three de novo rectocoeles. One cystocoele and one rectocoele
are asymptomatic (Aa = −1, Ap = −1), and two women
with rectocoele (Ap = 0) underwent fascial repair. Among 16
women in the posterior only group, four had a subsequent
prolapse. Three, all remaining asymptomatic, developed a de
novo cystocoele (Aa = −1, Ba = −1, Aa = +1). The aﬀected
site was not recorded for the other.
Fourteen of 39 women treated with both anterior and
posterior Surgisis experienced further prolapse (Table 3).
Nine involved the anterior compartment, two the vault and
anterior wall, one the vault only, one the posterior compart-
ment only, and, in one, the site was not documented. Three
of the anterior compartment recurrences were symptomaticObstetrics and Gynecology International 3
Table 1: Patient characteristics and preoperative assessments.
Characteristic Number Percent
Age in years (median, range) 66 (40–84)
Weight in kg (median, range) 75 (48–110)
Parity (median, range) 2 (0–4)
Previous treatments
Oestrogens 46 70.8
Physiotherapy 49 75.4
Pessary 38 58.5
Hysterectomy 28 43.1
Prolapse surgery 27 41.5
Prolapse stage (POPQ) [11]
2 36 55.4
3 28 43.1
41 1 . 5
Presenting symptoms
Vaginal lump 53 81.5
Bladder symptoms 37 56.9
Urgency 28 43.1
Stress 20 30.8
Hesitancy/retention 12 18.5
Recurrent infection 2 3.1
Bowel symptoms 26 40.0
Evacuation diﬃculty 22 33.8
Faecal/ﬂatal incontinence 4 6.2
Pain 7 10.8
Dyspareunia 3 4.6
Back pain 2 3.1
Dragging discomfort 1 1.5
Table 2: Success and failure rates according to the compartment
repaired.
Compartment
repaired
No. of
patients
Objective
cure∗
Subjective
cure∗ Failure
Anterior 10 (15.4%) 6 8 2
Posterior 16 (24.6%) 12 15 1
Both 39 (60.0%) 25 36 3
Total 65 (100%) 43 59 6
∗Objective cure is deﬁned as POPQ stage <2 at the last followup. Subjective
cure refers to women with no symptoms, no bulge beyond the hymen, and
happy with the result.
and underwent surgery with permanent polypropylene
mesh.
Overall,theanteriorrecurrenceratewas12of49(24.5%)
and the same site reoperation rate (planned and performed)
was 3 of 49 (6.1%). After anterior repair two women
developed a rectocoele that required repair. The posterior
recurrence rate was one in 55 (1.8%) with no reoperations
required.
Table 4 displays the timing and site of subsequent
prolapse regardless of the site repaired. There was a failure
Table 3: Site of recurrence or subsequent prolapse according to the
compartment repaired.
Site of subsequent
prolapse
Compartment repaired
Anterior
(n = 10)
Posterior
(n = 16)
Anterior and
posterior
(n = 39)
Apical — — 3
Anterior 1 3 11
Posterior 3 — 1
Not speciﬁed — 1 1
Total 4 4 14∗
∗Two women had a subsequent prolapse in two compartments (vault and
anterior wall).
Table 4: Success and failure rates according to the duration of
followup.
Duration of
followup
No. of
patients
Objective
cure∗
Subjective
cure∗ Failure
Up to 1 year 65 43 59 6
Up to 3 years 33 20 31 2
Up to 5 years 10 7 10 0
More than 5
years 323 0
∗O b j e c t i v ec u r ei sd e ﬁ n e da sP O P Qs t a g e<2 at the last followup. Subjective
cure refers to women with no symptoms, no bulge beyond the hymen, and
happy with the result.
rate of 29% (16% objective and 13% subjective) in women
followed up to a year. This rate did not change signiﬁcantly
for those followed up to ﬁve years, but absolute numbers are
small. Symptomatic recurrences did not appear to increase
over time.
4. Discussion
The quest for the ultimate prolapse repair continues
unabated despite the availability of various prosthetic and
graft materials. Although it is generally accepted that they
result in lower short-term recurrence rates, especially in
the anterior compartment, there are also substantial draw-
backs. These include signiﬁcant prosthesis- and graft-related
complications, diﬃculty treating subsequent failures, and no
demonstrated beneﬁt on quality of life and sexual function
[5,13–15].Theidealgraftmaterialwouldallowcorrectionof
vaginal anatomy whilst maintaining pelvic organ function. It
would be biocompatible, inert, sterile, resistant to physical
modiﬁcation, of mechanical stress and shrinkage, readily
available, inexpensive, with minimal risks of infection and
rejection [16].
Biological grafts from other species (xenografts) have
been used to repair hernias and pelvic organ prolapse for
many years [17]. They are thought to reduce complica-
tions of erosion, ﬁstula formation, and infection seen with
permanent prosthetic material [6]. Several xenografts are
currently used in vaginal reconstruction [17]. They diﬀer4 Obstetrics and Gynecology International
in species of origin (bovine or porcine), site of harvest
(pericardium, dermis, intestinal submucosa), sterilisation
process, and cross-linking during manufacture.
Surgisis is an acellular, three-dimensional lattice of colla-
gen, and extracellular matrix, not cross-linked, derived from
the submucosa of porcine small intestine. Being acellular,
Surgisis minimises risks of viral or prion transmission,
inﬂammatoryresponses, rejection, andexposure[7,16].The
absence of chemical cross-linking facilitates colonisation by
host cells and avoids encapsulation and poor ﬁxation at the
graft-host interface, which could weaken the repair [6]. The
matrix encourages host angiogenesis, connective tissue and
epithelial diﬀerentiation and ingrowth, eventually replacing
the graft with constructive connective tissue remodelling
instead of scar tissue [18]. Graft resorption is believed to
reduce long-term complications, such as graft exposure and
dyspareunia.Concernremains,however,aboutthedurability
of the repair after remodelling [6].
Apart from congress abstracts, there are very few studies
ontheuseofSurgisisinpelvicﬂoorrepair.Theseincludeone
randomised controlled trial of women undergoing anterior
compartment repair [8] and three retrospective comparative
studies [7, 9, 10]. The randomised trial with 56 patients
compared Surgisis with traditional anterior colporrhaphy
[8]. The anatomical cure (POPQ Stage 0 or 1) at 12 months
was 86.2% with Surgisis and 59.3% with conventional
colporrhaphy [8]. Improvement in quality of life was similar
in both groups. More intraoperative complications, mainly
“excessive” blood loss without transfusion, occurred in the
Surgisis group. There were no graft infections or expo-
sures. In women treated for recurrent cystocoele, anterior
colporrhaphy had a much higher failure rate than Surgisis
(57.1% versus 14.3%). This supports the contention that
womenwithrecurrentprolapsearelikelytohaveintrinsically
weak support tissue or poor healing, beneﬁting most from
augmented repair.
Chaliha et al. [7] reported on 28 women undergoing
either colporrhaphy or Surgisis augmentation for anterior
prolapse and found an improvement in objective measure-
ments and quality of life at six months, but no diﬀerence
at two years. However, lack of randomisation and small
numbers limit interpretation of these data. A comparative
study by Mouritsen et al. [9], with a median followup of
three years, found better results with Surgisis than with
anterior or posterior colporrhaphy, but the diﬀerence was
not statistically signiﬁcant. Reid and Luo [10] compared 108
bridging graft vaginal paravaginal repairs (89 using Surgisis)
with 59 native tissue cystocoele repairs [10]. With bridging
grafts, cystocoele persistence was reduced from 10.2% to
4.6% and late recurrences from 22.6% to 4.9% [10].
A randomised trial reported by Paraiso et al. [19]i so f t e n
considered relevant to the use of porcine implants in rec-
tocoele repair [14]. It compared three diﬀerent techniques,
one of which included a porcine-derived graft (Fortagen).
There was a signiﬁcant improvement in quality of life and
sexual function in all groups, but the Fortagen group had the
highest anatomical failure rate. However, Fortagen is cross-
linked and more prone to encapsulation and poor ﬁxation at
the graft-host interface than Surgisis.
The current study presents 65 women followed for
a variable time up to six years. Compared with other
studies mentioned, our failure rate is slightly higher for
the anterior compartment, but lower for the posterior
compartment.Ourresults,relatingpredominantlytowomen
with previous surgery or considered at increased risk of
recurrence, support the use of Surgisis. Most subjective
failures also occurred in the unrepaired compartment. The
anterior only group had four “failures,” two of which were
symptomatic rectocoeles that underwent repair. Of the four
“failures” in the posterior only group, three were anterior
and they remain asymptomatic. The development of de novo
prolapse after repair could be due to a delayed manifestation
of generally weak support tissue, undertreatment (prolapse
in one compartment missed or masked by prolapse in
another), or alteration in the vaginal axis, predisposing to
later prolapse. More often than not, pelvic ﬂoor dysfunction
is not conﬁned to a single support structure [20]. Subclinical
poor support in a particular compartment may thus become
more manifest after correction of visible prolapse in another
[20].
Thus far, Surgisis shows most promise in the treatment
of recurrent rectocoele. At Flinders urogynaecology, fascial
repair remains the primary approach for posterior prolapse.
Surgisis is used for recurrences, and permanent mesh is used
when both these procedures failed. For anterior prolapse,
the approach is dictated by the integrity of the levator
muscle [21], vaginal rugation, and vaginal sacculation. With
clinically intact levators and no sacculation, anterior col-
porrhaphy is the primary approach. With avulsed levators,
intact rugae, and no sacculation, laparoscopic paravaginal
repair is preferred. The remaining cases of cystocoele are at
high risk of recurrence with native tissue repair and require
graft or prosthetic augmentation. In these circumstances,
Surgisis is used for the primary repair and permanent mesh
for recurrences.
In general, the frequency of recurrence after prolapse
repair increases with time [22]. There were no indications
to that eﬀect in our study. This suggests that Surgisis, when
eﬀective, achieves a durable result, perhaps because the new
connective tissue is stronger than the original or because
the graft oﬀers critical support while the new connective
tissuegainsinstrength.However,75%oftheoperationswere
performed between 2007 and 2009, resulting in only 10 with
a followup of more than three years. This emphasises the
well-recognized need for long-term followup after prolapse
surgery, diﬃcult to achieve as it may be, particularly when
people remain asymptomatic.
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